Completing data — refresh the page later to see the latest
21055-37-8COC(=O)CN=C=SGOWGDPFDGIPFIK-UHFFFAOYSA-N21055-37-8DTXSID30175275Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P261, P264, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 6 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Uses2-Isothiocyanoacetate methyl ester can be used as a pharmaceutical synthesis intermediate. It can be prepared by reacting glycine methyl ester hydrochloride with phosgene. It can be used to prepare compound (R)-2-(3(1-(4-fluorophenyl)ethyl)thiourea)acetate methyl ester. This compound can be used as a secretase regulator (including inhibitors, antagonists, etc.) to treat various diseases, including central nervous system disorders such as neurodegenerative diseases such as Alzheimer's disease, and other diseases related to amyloid protein deposition.